Corrigendum to 'Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival': [Annals of Oncology Volume 32, Issue 8, August 2021, Pages 1015-1024].

Slamon, D J; Neven, P; Chia, S; Jerusalem, G; De Laurentiis, M; Im, S; Petrakova, K; Valeria Bianchi, G; Martín, M; Nusch, A; Sonke, G S; De la Cruz-Merino, L; Beck, J T; Ji, Y; Wang, C; Deore, U; Chakravartty, A; Zarate, J P; Taran, T; Fasching, P A

Slamon, D J; Neven, P; Chia, S; Jerusalem, G; De Laurentiis, M; Im, S; Petrakova, K; Valeria Bianchi, G; Martín, M; Nusch, A; Sonke, G S; De la Cruz-Merino, L; Beck, J T; Ji, Y; Wang, C; Deore, U; Chakravartty, A; Zarate, J P; Taran, T; Fasching, P A.

Afiliação

Slamon DJ; David Geffen School of Medicine at UCLA, Los Angeles, USA. Electronic address: dslamon@mednet.ucla.edu.
Neven P; Multidisciplinary Breast Centre, Universitair Ziekenhuis Leuven, Leuven, Belgium.
Chia S; British Columbia Cancer Agency, Vancouver, Canada.
Jerusalem G; CHU Liege and Liège University, Liège, Belgium.
De Laurentiis M; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy.
Im S; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Petrakova K; Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Valeria Bianchi G; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy.
Martín M; Instituto de Investigación Sanitaria Gregorio Marañon, Centro de Investigación Biomédica en Red de Cáncer, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid, Spain.
Nusch A; Practice for Hematology and Internal Oncology, Velbert, Germany.
Sonke GS; Netherlands Cancer Institute/Borstkanker Onderzoek Groep Study Center, Amsterdam, The Netherlands.
De la Cruz-Merino L; Hospital Universitario Virgen Macarena, Seville, Spain.
Beck JT; Highlands Oncology Group, Fayetteville, USA.
Ji Y; Novartis Pharmaceuticals Corporation, East Hanover, USA.
Wang C; Novartis Pharma AG, Basel, Switzerland.
Deore U; Novartis Pharmaceuticals Corporation, East Hanover, USA.
Chakravartty A; Novartis Pharmaceuticals Corporation, East Hanover, USA.
Zarate JP; Novartis Pharmaceuticals Corporation, East Hanover, USA.
Taran T; Novartis Pharma AG, Basel, Switzerland.
Fasching PA; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen, Erlangen, Germany.

Ann Oncol ; 32(10): 1307, 2021 Oct.

Article em En | MEDLINE | ID: mdl-34412950

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google